Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

Autor:	M A Frolova, Ya I Kochetkova, V A Chubenko, N M Volkov, F V Moiseenko, T V Garmarnik, D M Ponomarenko, A E Orlov, Yu V Kostalanova, Yu Yu Makarycheva, A A Nizegorodzeva
Jazyk:	ruština
Rok vydání:	2018
Předmět:	breast cancer ribociclib letrozole Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Современная онкология, Vol 20, Iss 2, Pp 29-37 (2018)
Druh dokumentu:	article
ISSN:	1815-1434 1815-1442
DOI:	10.26442/1815-1434_2018.2.29-37
Popis:	The article represents case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in Russian Federation. Russian oncologists’ experience has demonstrated the high efficacy and manageable safety profile of the ribociclib treatment in patients in clinical practice.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/ff1e6155409e4e32bdd5d8155e1292c9 Zobrazit plný text záznamu View record in DOAJ